Literature DB >> 7330755

Pelvic inflammatory disease: etiology, diagnosis, and treatment.

R L Sweet.   

Abstract

Coincident with the epidemic of sexually transmitted diseases, the incidence of pelvic inflammatory disease has risen sharply in recent years. Pelvic inflammatory disease is a major direct cause of infertility; in addition, it leads to ectopic pregnancies and chronic inflammatory residua requiring surgical intervention. This threat to the future fertility of women is rendered more serious by the difficulty of making a correct diagnosis and the likelihood that faulty diagnosis will result in inadequate treatment. Pelvic inflammatory disease is caused not only by Neisseria gonorrhoeae but also by Chlamydia trachomatis, genital tract mycoplasmas, and mixed bacteria from the endogenous vaginal and cervical flora, especially anaerobes. Diagnostic criteria include (1) lower abdominal and pelvic pain, (2) lower abdominal tenderness, (3) elevation of erythrocyte sedimentation rate, (4) adnexal inflammatory mass, and (5) presence of leukocytes and bacteria in the peritoneal fluid. Early diagnosis and prompt treatment appear to be crucial in preventing infertility. No studies have evaluated prospectively the relative advantages of inpatient vs. outpatient management of acute pelvic inflammatory disease. The recommendations of the Centers for Disease Control (CDC; Atlanta, Ga.) for outpatient treatment and the results of a multi-hospital collaborative study using the CDC regimens are discussed. Criteria for hospitalization and parenteral antibiotic therapy are presented.

Entities:  

Keywords:  Adnexitis--etiology; Biology; Diseases; Examinations And Diagnoses; Genital Effects, Female; Genitalia; Genitalia, Female; Infections; Infertility; Iud; Pelvic Inflammatory Disease; Physiology; Reproductive Tract Infections; Sex Behavior; Sexually Transmitted Diseases; Treatment; Urogenital System

Mesh:

Substances:

Year:  1981        PMID: 7330755

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  5 in total

1.  Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study.

Authors:  Maria Trent; Debra Bass; Roberta B Ness; Catherine Haggerty
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

2.  The tender uterus.

Authors:  S S Im
Journal:  Can Fam Physician       Date:  1987-08       Impact factor: 3.275

3.  Culture versus direct specimen test: comparative study of infections with Chlamydia trachomatis in Viennese prostitutes.

Authors:  A Stary; W Kopp; W Gebhart; J Söltz-Szöts
Journal:  Genitourin Med       Date:  1985-08

4.  Field-delivered therapy increases treatment for chlamydia and gonorrhea.

Authors:  Katherine C Steiner; Veronica Davila; Charlotte K Kent; Janice K Chaw; Lyn Fischer; Jeffrey D Klausner
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

Review 5.  Beta-lactams in sexually transmitted diseases: rationale for selection and dosing regimens.

Authors:  D Kunimoto; R Brunham; A Ronald
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.